Here's why I think the pet industry is a great investment

The pet industry has a lot of growth on offer.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The pet industry may not seem like an exciting industry, but I think it's one of the best. We really love our furry children and we're willing to pay a pretty penny on them.

Here are some good reasons why you should be interested in the pet industry:

Growing number of pets

The pet population has been steadily growing alongside the human population. In-fact, the ratio of pets to humans is growing, meaning that the pet population is growing faster than humans.

There are now 4.8 million dogs and 3.8 million cats in Australia.

High recurring revenue

Recurring revenue is a pleasing factor in any industry. Around 80% of dogs and two thirds of cats visit a vet each year, which provides a regular and growing source of earnings for vets like Greencross Limited (ASX: GXL).

Growth of miscellaneous services

There's a wide range of additional pet services that businesses are jumping on. Grooming, pet insurance, puppy school and pet hotel bookings are just a few of the services that Greencross is tapping into.

Overall growth

All of these factors have helped the national pet industry grow by 42% since 2013 to be worth $12 billion.

If Greencross and National Veterinary Care Ltd (ASX: NVL) can keep growing in this sector, then they could be good winners.

National Vet Care should beat the market because of how many vet clinics it's likely to acquire over the next few years.

Greencross should beat the market because of how low its price/earnings ratio is and its plan to co-locate vets inside Petbarns.

Foolish takeaway

Greencross is currently trading at 13x FY18's estimated earnings with a grossed-up dividend yield of 5.05%.

National Vet Care is trading at 32x FY17's earnings with a grossed-up dividend yield of 1.61%.

I think both are buys at today's prices and I'm fairly confident they will beat the market over the next year and five years.

Motley Fool contributor Tristan Harrison owns shares of Greencross Limited and NATVETCARE FPO. The Motley Fool Australia owns shares of Greencross Limited and NATVETCARE FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »